OTC · Medical - Pharmaceuticals

GABY Inc. (GABLF) Stock

$0.00 OTC: GABLF Healthcare

GABY Inc., operating through its subsidiaries, specializes in the manufacturing, commercialization, and retail distribution of cannabis-centric consumer packaged goods throughout the United States. The company's diverse portfolio includes a wide array of cannabis offerings, such as raw flowers, concentrated extracts, pre-rolled joints, edible products, topical solutions, tinctures, and various other goods infused with or derived from cannabis and hemp.

Valuation

MetricValue
Price$0.00
Market Cap$2.66M
P/E Ratio-0.04
P/B Ratio-0.04
P/S Ratio0.12
EPS (TTM)$-0.04
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE126.09%
ROA-131.82%
ROCE-23.64%
Gross Margin-4.55%
Operating Margin-9.09%
Net Margin-131.82%
Debt/Equity-1.35
Current Ratio0.13

Annual Financials (USD)

Metric20182019202020212022
Revenue$1.0M$8.0M$4.0M$26.0M$22.0M
Operating Profit$-5.0M$-10.0M$-8.0M$-2.0M$-2.0M
Net Profit$-6.0M$-17.0M$-11.0M$-10.0M$-29.0M
EPS$-0.09$-0.12$-0.05$-0.02$-0.04
Op Margin-442.4%-125.6%-192.1%-5.8%-7.3%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$3.0M$15.0M$4.0M$52.0M$22.0M
Total Liabilities$3.0M$11.0M$8.0M$49.0M$46.0M
Cash$0$1.0M$0$3.0M$1.0M
Borrowings$0$7.0M$3.0M$35.0M$31.0M

Latest News

Puzzle solutions for Sunday, Aug. 02, 2026 USA TODAY · Aug 2, 2026 Billionaire Steve Cohen Is Buying This Overlooked Stock While Dumping Big Tech Motley Fool · Aug 2, 2026 Fire toll mounts in Greece as blazes spread AFP · Aug 2, 2026 My son, 36, is going through a divorce and wants to move home — how can I help him without sacrificing my retirement? Moneywise · Aug 2, 2026 Popular CT bank embracing artificial intelligence with new AI role Hartford Courant · Aug 2, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-4.0M$-13.0M$-1.0M$0$1.0M
Investing Cash Flow$-1.0M$-3.0M$0$-2.0M$0
Financing Cash Flow$1.0M$4.0M$0$5.0M$-2.0M
Net Cash Flow$0$0$0$3.0M$-2.0M
Free Cash Flow$-4.0M$-14.0M$-1.0M$0$1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.42
FCF Yield39.52%
Quick Ratio0.12
Interest Coverage-0.49
Return 1Y
Return 3Y
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATIPATI Physical Therapy, Inc. $0.68 +0.00% -0.03 $2.98M 0.00%
AWKNFAwakn Life Sciences Corp. $0.07 +0.00% -0.28 $2.71M 0.00%
CIMVFPideka Group Inc. $0.01 +0.00% -1.16 $2.51M 0.00%
CPYTCarePayment Technologies, Inc. $0.00 0.00 $1667 0.00%
DLTNFDelta 9 Cannabis Inc. $0.01 -1.95% -0.05 $3.04M 0.00%

About GABY Inc.

GABY Inc., operating through its subsidiaries, specializes in the manufacturing, commercialization, and retail distribution of cannabis-centric consumer packaged goods throughout the United States. The company's diverse portfolio includes a wide array of cannabis offerings, such as raw flowers, concentrated extracts, pre-rolled joints, edible products, topical solutions, tinctures, and various other goods infused with or derived from cannabis and hemp. These items are marketed under distinct brand identities, specifically Mankind, Kind Republic, Lulu's, 2Rise, and Dank Space. Founded in 2003, the enterprise was formerly known as Gabriella's Kitchen Inc. until it officially rebranded to GABY Inc. in September 2019. Its corporate headquarters are situated in Calgary, Canada.

GABY Inc. (GABLF) stock trades at $0.00 with a market capitalization of $2.66M. The stock is valued at a price-to-earnings (P/E) ratio of -0.04, price-to-book of -0.04, price-to-sales of 0.12. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, GABY Inc. generates a return on equity (ROE) of 126.09% — well above the market average, a sign of a high-quality business, return on capital employed of -23.64%, an operating margin of -9.09%, a net profit margin of -131.82%.

Official website: www.gabyinc.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides